Brief: Absci Q3 Operating Expenses USD 30.596 Million
Nov 12 (Reuters) - Absci Q3 operating income USD -28.895 million vs. IBES estimate USD -23.4 million. * Q3 basic EPS USD -0.24 * Q3 net income USD -27.398 million vs. IBES estimate USD -23.6 million * Q3 pretax profit USD -27.361 million vs. IBES estimate USD -22.9 million
Recent news on AbSci
See all newsAbsci Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Absci Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Absci Q3 revenue misses estimates, net loss widens on R&D spends
Focus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave